Immunogenicity 15710
Sample ID
3713
Response
Positive
Tumor Type
Melanoma
Gene Symbol
SEC22C
Transcript ID
None
HLA INFO
B*44:03
TCR INFO
TRBVBV29-1
CDR3BSVEDRRGPFYGYTF
Full length protein sequence (303 aa)
MSVIF
1
FACVV
6
RVRDG
11
LPLSA
16
STDFY
21
HTQDF
26
LEWRR
31
RLKSL
36
ALRLA
41
QYPGR
46
GSAEG
51
CDFSI
56
HFSSF
61
GDVAC
66
MAICS
71
CQCPA
76
AMAFC
81
FLETL
86
WWEFT
91
ASYDT
96
TCIGL
101
ASRPY
106
AFLEF
111
DSIIQ
116
KVKWH
121
FNYVS
126
SSQME
131
CSLEK
136
IQEEL
141
KLQPP
146
AVLTL
151
EDTDV
156
ANGVM
161
NGHTP
166
MHLEP
171
APNFR
176
MEPVT
181
ALGIL
186
SLILN
191
IMCAA
196
LNLIR
201
GVHLA
206
EHSLQ
211
VAHEE
216
IGNIL
221
AFLVP
226
FVACI
231
FQCYL
236
YLFYS
241
PARTM
246
KVVLM
251
LLFIC
256
LGNMY
261
LHGLR
266
NLWQI
271
LFHIG
276
VAFLS
281
SYQIL
286
TRQLQ
291
EKQSD
296
CGV
301
Mutation Information
DNA mutation:
None
Peptide Range:
210 ~ 218
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"AEHSLQVAH
||||||||.
Mutant:
AEHSLQVAY"
Cancer Immunol Res, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensGene Name (from Reference) SEC22C
Checkpoint
Blockade
None
ACT
Y
Vaccination
N
Curative
Effect
durable regression
minimal_peptide
Y
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
B cells
Assay
None